Vistin Pharma ASA (OSL:VISTN)
19.80
-0.20 (-1.00%)
At close: Dec 1, 2025
Vistin Pharma ASA Revenue
Vistin Pharma ASA had revenue of 108.84M NOK in the quarter ending September 30, 2025, with 2.84% growth. This brings the company's revenue in the last twelve months to 455.25M, up 6.73% year-over-year. In the year 2024, Vistin Pharma ASA had annual revenue of 429.50M, down -2.01%.
Revenue (ttm)
455.25M
Revenue Growth
+6.73%
P/S Ratio
1.93
Revenue / Employee
6.24M
Employees
75
Market Cap
878.02M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 429.50M | -8.83M | -2.01% |
| Dec 31, 2023 | 438.33M | 133.48M | 43.78% |
| Dec 31, 2022 | 304.85M | 26.23M | 9.41% |
| Dec 31, 2021 | 278.62M | 24.72M | 9.73% |
| Dec 31, 2020 | 253.91M | 25.78M | 11.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 662.18M |
| Nordhealth AS | 590.33M |
| Navamedic ASA | 539.42M |
| Photocure ASA | 537.59M |
| Omda AS | 476.29M |
| Gentian Diagnostics ASA | 172.52M |
| ContextVision AB | 115.15M |
| ArcticZymes Technologies ASA | 109.99M |